Although Taiwan ranked second in the world for medical services in a 2000 report by the Economist Intelligent Unit, inbound medical tourism remains a fledgling industry, lagging behind South Korea, Singapore and Thailand, which have promoted the sector for more than a decade.
Given the efforts to target visitors from Japan and China — two of Taiwan’s biggest sources of tourists — industry insiders say medical tourism could do more than bring in revenue, strengthening Taiwan’s prominence in the field of medicine as well.
Taiwan Medical Tourism Development Association (TMTDA, 台灣觀光醫療發展協會) head Allen Lee (李昆侖) said that if just 5 percent of an estimated 2.2 million Japanese and Chinese tourists over a one-year period spent NT$10,000 (US$305) each on having physicals in Taiwan, medical centers would earn NT$1.1 billion in income.
“Our share of the pie could be even bigger, given that the sector’s output is US$250 billion globally,” Lee said.
The niche market has become increasingly lucrative, with experts estimating that medical tourism could earn India as much as US$2.2 billion per year by 2012.
Singapore has set a goal of attracting 1 million “medical tourists” per year by 2012 and generating US$3 billion in revenue, or 1.6 percent of GDP. Thailand, meanwhile, has established itself as a regional center for spa treatments.
Lee said Taiwan was particularly well-positioned to vie for medical tourists from China, given the cultural proximity, common language and popularity of its tourist attractions.
A 40-year-old Beijing visitor surnamed Hsu (�?greed.
Hsu and 16 other members of a 32-person tour group from China’s capital received positron emission tomography (PET) examinations at Shin Kong Wu Ho-Su Memorial Hospital (新光醫院) last Monday at a cost of 6,000 yuan (US$878) each.
“The hospital’s services are very good and its equipment is pretty new,” he told the Taipei Times after undergoing the high-end health check.
Hsu said he had heard good things about Taiwan’s medical services by word of mouth after a group from Guangzhou, the first to visit Taiwan for medical tourism, were very satisfied with their experience in June.
The same PET check costs between 10,000 yuan and 12,000 yuan in China, said Beijing MJ Health Screening Co (美兆健檢中心), the organizer of the tour group.
The Beijing group, which wrapped up its six-day trip on Friday, was the second Chinese tour group to visit Taiwan for a combination of health checks, spa treatments and sightseeing since June.
Given Taiwan’s medical expertise and services, many middle and high-income Beijing residents should be interested in visiting Taiwan, despite the fact that hospitals and clinics in their home city offer an array of state-of-the-art medical equipment, said Li Ping (李萍), the administrator of Beijing MJ Health Screening, which has 30,000 members in Beijing alone.
“We look at Taiwan’s quality of medical services,” she said. “A price range of between 6,000 yuan and 8,000 yuan will be very acceptable for Chinese who want to get health checks.”
Li said Chinese are also impressed by the National Health Insurance, under which citizens and residents are covered by the kind of social safety net that Chinese authorities are considering implementing.
Eyeing the market’s potential, Shin Kong Hospital has signed an agreement with Shin Kong and HNA Life Insurance Co (新光海航人壽) — a 50-50 joint venture between China’s Hainan Airlines Co (海航集團) and Taiwan’s Shin Kong Life Insurance Co (新光人壽) — and Beijing-based MJ Health Screening and SweetMe Hotspring Resort (水美溫泉會館) to encourage policyholders and members of these companies to visit for medical tourism.
The business is still in its trial period, Beijing MJ Health Screening president Jack Tai (戴明哲) said, adding that three more medical tourist groups from Beijing would travel to Taiwan in the next three months.
“In future, we hope there will be a group of more than 30 members visiting Taiwan each month,” Tai said.
Leu Jyh-gang (呂至剛), chief of Shin Kong Hospital’s department of health management, said he was confident that Taiwan could tap into increasing health demand in China.
He said Taiwan had 30 PET scanners nationwide, two of which are owned by Shin Kong and cost around NT$60 million each. Beijing has four scanners out of a total of 40 in all of China.
Coming to Taiwan would mean easier access and less waiting time for potential patients, while Taiwanese prices are lower, he said.
More importantly, Leu said, Taiwanese doctors have greater expertise in reading scan results, which are pointless if misinterpreted.
Shin Kong Hospital’s scanners have helped detect cancer in more than 300 patients, or 1.3 percent of its total 28,000 patients since 2001, “all of whom are still alive as a result of early [detection and] treatment,” Leu said.
Moreover, the hospital reserves 20 scan slots per month for patients from abroad.
In addition to PET and other health checks, Taiwan’s medical services should be able to outperform other regional rivals in attracting tourists seeking micro cosmetic surgery, liver transplants, heart surgery and artificial joint replacements, said Mark Lee (李孟鴻), director of Jen Chi Hospital’s (仁濟醫院) dialysis center, which has been supporting tour trips by visiting dialysis patients.
In the case of Japanese tourists, dental implant surgery or Chinese medicine packaged with hot-spring treatments for a reasonable price are very attractive, Allen Lee said.
But local hospitals are lagging behind in terms of international marketing and resources to develop the industry, Mark Lee said. This, combined with tight regulations, poses a hurdle to the medical tourism sector, he said.
As the medical services sector is considered non-profit, government regulations bar hospitals from advertising their prices to attract foreign clients.
To appeal to potential medical tourists abroad, authorities need to loosen restrictions on advertising, Mark Lee said, adding that Taiwan must also simplify the visa application process for medical tourists.
Chen Shee-han (陳興漢), director of the international health center at Taoyuan-based Min-Sheng Healthcare Hospital (敏盛醫療), said hospitals were sending mixed signals by promoting medical services abroad without making the competitiveness of their prices known.
Min-Sheng is the first Joint Commission International accredited hospital in Taiwan, specializing in knee replacements. The procedure costs approximately one-fifth of the price in the US.
TECH RACE: The Chinese firm showed off its new Mate XT hours after the latest iPhone launch, but its price tag and limited supply could be drawbacks China’s Huawei Technologies Co (華為) yesterday unveiled the world’s first tri-foldable phone, as it seeks to expand its lead in the world’s biggest smartphone market and steal the spotlight from Apple Inc hours after it debuted a new iPhone. The Chinese tech giant showed off its new Mate XT, which users can fold three ways like an accordion screen door, during a launch ceremony in Shenzhen. The Mate XT comes in red and black and has a 10.2-inch display screen. At 3.6mm thick, it is the world’s slimmest foldable smartphone, Huawei said. The company’s Web site showed that it has garnered more than
CROSS-STRAIT TENSIONS: The US company could switch orders from TSMC to alternative suppliers, but that would lower chip quality, CEO Jensen Huang said Nvidia Corp CEO Jensen Huang (黃仁勳), whose products have become the hottest commodity in the technology world, on Wednesday said that the scramble for a limited amount of supply has frustrated some customers and raised tensions. “The demand on it is so great, and everyone wants to be first and everyone wants to be most,” he told the audience at a Goldman Sachs Group Inc technology conference in San Francisco. “We probably have more emotional customers today. Deservedly so. It’s tense. We’re trying to do the best we can.” Huang’s company is experiencing strong demand for its latest generation of chips, called
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Vanguard International Semiconductor Corp (世界先進) and Episil Technologies Inc (漢磊) yesterday announced plans to jointly build an 8-inch fab to produce silicon carbide (SiC) chips through an equity acquisition deal. SiC chips offer higher efficiency and lower energy loss than pure silicon chips, and they are able to operate at higher temperatures. They have become crucial to the development of electric vehicles, artificial intelligence data centers, green energy storage and industrial devices. Vanguard, a contract chipmaker focused on making power management chips and driver ICs for displays, is to acquire a 13 percent stake in Episil for NT$2.48 billion (US$77.1 million).